Professional Documents
Culture Documents
Amniofix Injectable Brochure
Amniofix Injectable Brochure
Process retains the amniotic growth factors
and cytokines inherent in this tissue. The
result is an injectable product that offers
surgeons a clear advantage.
Conta|ns a comb|nat|on ol rowtH
factors unique to placental tissue
beduces |nNammat|on at tHe |nject|on s|te
LnHances tHe norma| wound Hea||n
process
Product Offering
Safety
AmnioFix Injectable is processed using Purion,
a unique approach that provides an added level
of tissue safety and ease of use.
Lllect|ve m|crob|a| reduct|on, us|n
Purion System
1erm|na| ster|||zat|on us|n LBeam,
which does not harm AmnioFix Injectable
/mn|ol|x lnjectab|e |s never treated w|tH
|utara|deHyde or otHer cross||nk|n
agents, reducing concerns about potential
cytotoxicity
Ease of Use
AmnioFix Injectable has been specically
processed for optimum handling.
0ry powder preservat|on lor s|mp|e m|x|n
and application
byear sHe|l ||le at room temperature;
no special storage required
Soft Tissue Healing
In vivo and in vitro studies have shown that
the properties of amniotic membrane help
to reduce |nNammat|on and scar t|ssue
formation.
1,2,3,4
For use as an injection into
soft tissue, AmnioFix Injectable provides an
ellect|ve so|ut|on to reduce |nNammat|on and
support the natural healing process:
Inammation Reduction
Human amniotic tissue has been proven to
conta|n ant| |nNammatory prote|ns sucH as
|nter|euk|n |ll receptor antaon|st; t|ssue
|nH|b|tors ol meta||oprote|nase |1llls ,
Z, 3, 4; and llC
Non-immunogenic
Human amn|ot|c t|ssue |s non|mmunoen|c
and does not elicit a substantial immune
response
Ordering Information
Customer 3erv|ce: bb.4//.4Z9
Email: customerservice@mimedx.com
bC CHasta|n Center B|vd., 3u|te bC, bennesaw, 0/ 3C44 www.m|medx.com
AmnioFix